SPCS1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.164200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.403800E-01
Normal-vs-Stage2
5.452200E-01
Normal-vs-Stage3
6.649000E-01
Normal-vs-Stage4
3.271800E-01
Stage1-vs-Stage2
5.028000E-02
Stage1-vs-Stage3
1.206600E-01
Stage1-vs-Stage4
4.505800E-01
Stage2-vs-Stage3
2.093200E-01
Stage2-vs-Stage4
7.022200E-01
Stage3-vs-Stage4
1.991840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.107400E-01
Normal-vs-AfricanAmerican
7.328600E-01
Normal-vs-Asian
5.505600E-01
Caucasian-vs-AfricanAmerican
5.783200E-01
Caucasian-vs-Asian
6.544200E-01
AfricanAmerican-vs-Asian
7.762000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.408600E-01
Normal-vs-Female
4.958400E-01
Male-vs-Female
9.651400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.740000E-01
Normal-vs-Age(41-60Yrs)
4.080400E-01
Normal-vs-Age(61-80Yrs)
5.899600E-01
Normal-vs-Age(81-100Yrs)
4.520000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.519800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.101600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.256000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.842400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.962000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.305200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.357000E-01
Normal-vs-Daily Drinker
5.162400E-01
Normal-vs-Weekly Drinker
6.997200E-01
Normal-vs-Occasional Drinker
2.768600E-01
Normal-vs-Social Drinker
8.105000E-01
Non Drinker-vs-Daily Drinker
4.348000E-01
Non Drinker-vs-Weekly Drinker
9.018200E-01
Non Drinker-vs-Occasional Drinker
5.452500E-02
Non Drinker-vs-Social Drinker
6.750000E-01
Daily Drinker-vs-Weekly Drinker
4.860200E-01
Daily Drinker-vs-Occasional Drinker
3.293600E-01
Daily Drinker-vs-Social Drinker
3.501800E-01
Weekly Drinker-vs-Occasional Drinker
1.148840E-01
Weekly Drinker-vs-Social Drinker
8.042200E-01
Occasional Drinker-vs-Social Drinker
7.027900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.724200E-01
Normal-vs-Grade 2
1.130410E-01
Normal-vs-Grade 3
1.382240E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.315200E-01
Grade 1-vs-Grade 3
6.268800E-01
Grade 1-vs-Grade 4
2.724200E-01
Grade 2-vs-Grade 3
7.771000E-01
Grade 2-vs-Grade 4
1.130410E-01
Grade 3-vs-Grade 4
1.382240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.026400E-01
Normal-vs-NonDiabetic
5.106800E-01
Diabetic-vs-NonDiabetic
4.304200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.874800E-01
Normal-vs-NoPancreatitis
5.307800E-01
Pancreatitis-vs-NoPancreatitis
5.889600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.315000E-01
Normal-vs-N1
6.193200E-01
N0-vs-N1
2.340000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.709990E-01
Normal-vs-TP53-NonMutant
4.650600E-01
TP53-Mutant-vs-TP53-NonMutant
1.605390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
